Cresco Labs Inc. (CRLBF) Gains from Investment Securities (2020 - 2026)

Cresco Labs (CRLBF) has reported Gains from Investment Securities for 6 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Gains from Investment Securities changed N/A year-over-year to $1.0 million; the trailing twelve-month figure through Jun 2026 stood at $2.1 million (changed N/A YoY), and the FY2025 full-year result was -$1.1 million, down 241.67% from the prior year.
• Gains from Investment Securities rose to $1.0 million in Q2 2026 per CRLBF's latest filing, from -$341000.0 in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $5.7 million in Q1 2022 and bottomed at -$341000.0 in Q1 2026.
• Historically, Gains from Investment Securities has averaged $1.8 million across 4 years, with a median of $1.2 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Gains from Investment Securities sank 49.0% in 2022, then sank 78.75% in 2023.
• Over 4 years, Gains from Investment Securities stood at $5.7 million in 2022, then tumbled by 78.75% to $1.2 million in 2023, then rose by 14.45% to $1.4 million in 2024, then declined by 23.8% to $1.0 million in 2026.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered $1.0 million, -$341000.0, and $1.4 million for Q2 2026, Q1 2026, and Q4 2024 respectively.